By Noah Weiland and Rebecca Robbins Hikma said it had reduced the cash portion of the offer as Boehringer Ingelheim’s generic drugs business in the U.S. had lower-than-expected sales.

German drugmaker Boehringer Ingelheim has its first regulatory approval for spesolimab, its antibody therapy for rare and life-threatening skin disorder generalised pustular psoriasis (GPP), in ...

The global veterinary biologics market is on a robust growth trajectory, with its valuation expected to reach USD 13,140.6 ...

The insurance industry can be seemingly opaque, and Jason enjoys breaking down confusing terms and products to help others ... The average cost for a vet visit is about $61, based on our research.

USA TODAY reported in April. While those costs encompass pet food and supplies, they also include veterinary care, which increased 7.6% from August 2023 to August 2024, according to the Bureau of ...

The U.S. FDA Breakthrough Therapy designation is for the treatment of adults with non-cirrhotic metabolic dysfunction-associated steatohepatitis ...

The heritage of Boehringer Ingelheim in developing medicines for ... Specifically for COPD, our products have been on the market for more than 40 years. Looking ahead, our aim is to significantly ...

Boehringer Ingelheim and Takeda are the only two pharmaceutical groups to be named among the 15 Global Top Employers for 2023, an award dedicated to companies that enrich the workplace environment.

Denmark's Zealand Pharma and German partner Boehringer Ingelheim have won the U.S. Food and Drug Administration's ...

Find out how this could enhance access to quality healthcare, with an emphasis on mental health services for vulnerable populations.

She's currently the Chief Medical Officer and Head of Medicine at Boehringer Ingelheim. Well, Dr. Hinsch Gylvin. Thanks for joining me today. That really has changed. So first and foremost ...